Roche is hoping to undercut hugely expensive rivals after the FDA approved its oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam). Evrysdi is the third treatment approved for SMA, an ...
Unresolved compliance issues at a manufacturing plant operated by Novo Nordisk have led to a complete response letter for Scholar Rock's lead drug for spinal muscular atrophy (SMA). The CRL is related ...
Materi latihan ini sangat tepat dimanfaatkan sebagai persiapan menghadapi Ujian Tengah Semester (UTS) atau Penilaian Tengah Semester (PTS) - Halaman 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback